CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 140 enrolled
Drug / intervention
IV Saline +3 moredrug
Likely dose
IV Dexamethasone 4mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02688530
NCT02688530Phase 4Completed

Intravenous Dexamethasone for Prolongation of Analgesia Following Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy: A Randomized, Controlled, Phase IV Dose-Response Study

Hospital for Special Surgery, New York·interventional·Posted Feb 23, 2016·Updated May 13, 2022

In Brief

A Phase 4 clinical trial evaluating IV Saline, IV Dexamethasone 4mg, and 2 other interventions for Shoulder Arthroscopy and Pain. Completed, enrolled 140 participants across 1 site.

Detailed Summary

Previous studies have confirmed that IV dexamethasone prolongs brachial plexus blocks. However, these studies only used fixed doses of IV dexamethasone at relatively high doses, which could potentially lead to increased glucose levels, delayed wound healing, and unintended side effects. There remains a paucity of research on the effective dose range of IV dexamethasone for the prolongation of supraclavicular blocks. The optimal dosage of IV dexamethasone for prolongation of analgesia vs. motor block prolongation from supraclavicular blocks in shoulder surgery has yet to be delineated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 23, 2016
Enrollment StartMay 1, 2016
Primary CompletionNov 19, 2017
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 10.4 years ago

Interventions

IV Salinedrug

IV Dexamethasone 4mgdrug

IV Dexamethasone 6mgdrug

IV Dexamethasone 8mgdrug